A rare cause of chylous ascites
Journal
Clinical Kidney Journal
Journal Volume
7
Journal Issue
1
Pages
71-72
Date Issued
2014
Author(s)
Abstract
We report a patient with end-stage renal disease status after two renal transplantations. Milky-like ascites was noted since the immunosuppressant agent was switched to sirolimus (1 mg/day). Chylous ascites was diagnosed owing to the triglyceride of dialysate to serum being 15.98:15.99. Series studies were all negative. It is highly suspected that the cause of chylous ascites is sirolimus related because surgically related lymph vessel injury happens most often 6 months after transplantation. Sirolimus-related chylous ascites is a rare cause of chylous ascites but the incidence rate increases after transplantation. Side effects of sirolimus include hyperlipidemia, anemia, thrombocytopenia, hepatotoxicity, delayed wound healing and a high rate of lymphoceles, lymph edema, and pulmonary alveolar proteinosis. Chylous ascitis has improved since the switch from sirolimus to other immunosuppressant agents. ? The Author 2013. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please email: journals.permissions@oup.com.
SDGs
Other Subjects
immunosuppressive agent; rapamycin; triacylglycerol; adult; anasarca; article; case report; catheter removal; chronic graft rejection; chylous ascites; dialysate; drug dose reduction; end stage renal disease; female; human; immunoglobulin A nephropathy; immunosuppressive treatment; kidney dysfunction; kidney graft rejection; kidney transplantation; leukocyte count; middle aged; oliguria; peritoneal dialysis; peritoneal dialysis catheter; priority journal; treatment outcome; triacylglycerol blood level; uremia
Type
journal article